Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Global Health

Our Global Health research covers the following research groups: Cardiovascular Disease; Deep Medicine; Infections; INTERGROWTH 21st; ME/CFS; Multimorbidity; Neurodevelopment; The Oxford Maternal & Perinatal Health Institute (OMPHI); Oxford University Global Surgery Group, SMARThealth Pregnancy and Urban Health.



Topics in this theme

Cardiovascular diseases are the leading cause of death in the world. The work of this research group integrates large databases of electronic health records, clinical trials, meta-analyses and digital technologies to better understand the determinants and consequences of cardiovascular disease, and how to improve quality of care and health outcomes.
Cardiovascular Disease
The Deep Medicine programme combines pioneering data analytic approaches, deep and machine learning techniques, and interdisciplinary collaboration to generate insights that will help tackle some of the major causes of death and disability worldwide.
Deep Medicine
How understanding the immunological status of HIV-infected pregnant women can help to identify which women are most likely to have babies born too early or too small, and support the development of novel preventative and therapeutic interventions.
Infections
An International Fetal and Newborn Growth Consortium dedicated to improving perinatal health through the development of new fetal and newborn growth standards, providing tools for the continuity of care from conception to 5 years of age.
INTERGROWTH-21st
Recent advances in medicine and health policy have led to an unprecedented increase in life expectancy. This longevity has also seen an increasing number of people, particularly older adults, suffering from two or more serious chronic diseases - a status known as multimorbidity.
Multimorbidity
The Morten research group aims to bring forward the day when ME/CFS can be cured, through cutting-edge biomedical research.
Myalgic Encephalomyeltis/Chronic Fatigue Syndrome
Evaluating neurodevelopment in different cultural settings is an integral component of early child development and is essential for observational and interventional studies focused on the first 1000 days of life.
Neurodevelopment
The Oxford Maternal & Perinatal Health Institute (OMPHI) works alongside Nuffield Department of Women's & Reproductive Health - bringing together world experts to resolve priority maternal and perinatal health problems on a global scale.
Oxford Maternal & Perinatal Health Institute (OMPHI)
The Nuffield Department of Women's & Reproductive health is part of the Oxford University Global Surgery Group (OUGSG), a interdepartmental group of the Medical Sciences Division for clinicians in surgery, anaesthesia, obstetrics and gynaecology with an interest in global surgical issues.
Oxford University Global Surgery Group
Every year, millions of women die from heart disease, stroke and complications of diabetes, with the greatest number of deaths occurring in low-resource settings, such as parts of rural India. Dr Jane Hirst and Dr D Praveen lead the SMARThealth Pregnancy programme, which aims to help community health workers identify women at risk and manage their healthcare in order to reduce premature deaths
SMARThealth Pregnancy: Improving women’s life-long health in rural India
The EveryPrem Project
The EveryPrem Project
Today, over 55% of the world’s population live in urban areas, with growth expected to accelerate in low-income and lower-middle-income countries over the next three decades. In order that this urbanisation is inclusive, safe and sustainable, it must be carefully managed to ensure that city spaces are ready to cater for the health of their expanding communities, and that of future citizens.
Urban Health